Fig. 9.1 Bilateral retroperitoneal metastasis of left testicular tumor, medializing aorta and vena cava Post-chemo residual masses are teratomas in 40% of NSGCT cases [11]. In a study including 210…
Fig. 3.1 CTV delineation for a muscle-invasive bladder cancer patient treated with definitive IGRT Fig. 3.2 Boost volume delineation for a muscle-invasive bladder cancer patient treated with definitive IGRT 3.4.3…
AJCC 7th Edition (2009) Note: new staging incorporates Gleason + PSA for risk group determination Primary tumor: T1—clinically inapparent tumor neither palpable nor visible by imaging T1a—incidental histologic finding in…
LN levels Boundaries of LN levels Recommended margins Superior Inferior Medial Lateral Anterior Posterior Internal iliac Bifurcation of the CI (usually the L5–S1 interspace) Superior portion of the coccygeal muscle…
© Springer International Publishing AG 2017Gokhan Ozyigit and Ugur Selek (eds.)Principles and Practice of Urooncologyhttps://doi.org/10.1007/978-3-319-56114-1_26 26. Quality Assurance of Modern Radiotherapy Techniques in Prostate Cancer Treatment Vildan Alpan1 , Yücel Sağlam1 and Steven Kirsner2 (1) Department of Radiation Oncology,…
Androgen inhibitors Abiraterone FDA approval For metastatic CRPC before chemotherapy For metastatic CRPC following docetaxel Orteronel (TAK-700) Phase III Maintenance therapy in patients with mCRPC previously treated with novel hormonal…
Study No of patients Randomization Results RTOG 85-31 [31] 977 RT vs. RT + LHRHa (continuous) Combined arm is better in all end points RTOG 86-10 [32] 456 RT vs. RT + 4 month CAB…
© Springer International Publishing AG 2017Gokhan Ozyigit and Ugur Selek (eds.)Principles and Practice of Urooncologyhttps://doi.org/10.1007/978-3-319-56114-1_17 17. Adjuvant or Salvage Radiotherapy in Postoperative Prostate Cancer Ugur Selek1, 2, Yasemin Bolukbasi1, 2 and Deborah A. Kuban2 (1) Department of Radiation Oncology,…
© Springer International Publishing AG 2017Gokhan Ozyigit and Ugur Selek (eds.)Principles and Practice of Urooncologyhttps://doi.org/10.1007/978-3-319-56114-1_6 6. Targeted Therapies and Immunotherapy in Bladder Cancer Mehmet Ali Nahit Şendur1 and Sercan Aksoy2 (1) Department of Medical Oncology, Ankara Yıldırım Beyazıt University,…
Fig. 7.1 A model of PCa progression. PCa starts as a localized tumor. In its natural progression, it typically metastasizes to the lymph nodes and then the bone, producing bone-forming…
